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1. Introduction
  Acute myocardial infarction and unstable angina pectoris 
are both referred to as acute coronary syndrome (ACS), 
which is currently one of the most common diseases that are 
harmful to human life and health. So far, it is considered 
that the important mechanism of ACS pathogenesis is that 
unstable plaque of coronary atherosclerosis falls apart and 
consequently leads to the formation of thrombus that blocks 
the lumen[1]. Since the tissues of plaque contain a lot of 
inflammatory cells and activated inflammatory cells can 
secrete excess pro-inflammatory cytokines which make 
the plaque of coronary artery easy to fall apart, lessening 
inflammation is helpful to make plaque stable, prevent and 
postpone the occurrence and development of ACS.
Objective: To explore the relation between K469E gene polymorphism of intercellular adhesion 
molecular-1 (ICAM-1) and the recurrence of ACS and cardiovascular mortality. Methods: A total 
of 185 patients with ACS hospitalized in Department of Cardiology in our hospital from Sep 2007 
to Sep 2008 were selected as objectives. Polymerase chain reaction was used to analyze K469E 
gene polymorphism of ICAM-1. According to the genotypes, they were divided into two groups: 
group with K allele (KK+KE) and group without K allele (EE). The two groups were followed up 
prospectively for five years and blood lipid, blood pressure, blood glucose, recurrence and 
death of ACS were collected when the patients left hospital. The relation between ICAM-1 gene 
polymorphism and the recurrence of ACS and cardiovascular mortality was analyzed by Logistic 
regression. Results: After long-term follow-up, it was found that ACS recurred on 71 cases 
(38.4%) and 10 cases died, among which 3 cases died of cardiovascular disease. The recurrence 
of ACS and cardiovascular mortality in group with K allele were remarkably higher than that 
in group without K allele (P<0.01). After multivariate Logistic regression adjusted ages, gender, 
weight indexes, TC, LDL-C, TG, smoking, drinking, family history of cardiovascular disease, 
history of hypertension and the severity of coronary artery disease, the risks of ACS recurrence 
and cardiovascular mortality in group with genotype KK+KE was 3.31 and 3.53 times of those in 
group with genotype EE respectively (P<0.01). When the independent variable of hypertension 
was introduced in regression analysis, the risks of ACS recurrence and cardiovascular mortality 
in group with K allele both decreased (P<0.05). When the independent variable of HDL-C 
was introduced, different genotypes of ICAM-1 weren’t relevant with ACS recurrence and 
cardiovascular mortality (P>0.05). Conclusions: K469E gene polymorphism of ICAM-1 was 
related to ACS recurrence and cardiovascular mortality, K allele probably an independent risky 
factor and hypertension and to which the level of HDL-C were closely related.
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  Intercellular adhesion molecule-1 (ICAM-1) mediates 
the activation of endothelial cells, triggers inflammatory 
reactions and contributes to the aggregation of a lot of 
inflammatory cells, which plays an important role in the 
formation of plaque. ICAM-1 gene has K469E polymorphism 
and many foreign studies reported that K469E polymorphism 
was closely related to stability of the plaque of coronary 
atherosclerosis[2,3]. The instability of plaque can lead to the 
recurrence of ACS and cardiovascular mortality. In the study, 
PCR technique was used to detect gene polymorphism. The 
value of predicting the recurrence of ACS and cardiovascular 
mortality by ICAM-1 gene polymorphism was discussed to 
provide basis for the individual prevention and treatment of 
high-risk patients.
2. Materials and methods
2.1. General data
   A total of 185 patients with ACS hospitalized in Department 
of Cardiology in our hospital from Sep 2007 to Sep 2008 were 
selected, including 128 male cases and 57 female cases, all 
of whom were in accordance with the diagnostic standards 
of ACS drafted by American College of Cardiology in 2002[4] 
and were confirmed by coronary arteriongraphy. All the 
patients were Han people and those with severe liver, renal 
insufficiency, autoimmune disease, tumor and acute or 
severe chronic infectious diseases were excluded. All the 
patients had no genetic connections and signed the informed 
consent and were approved by ethics committee before 
experiment.
2.2. Method
2.2.1. Sample collection and DNA extraction 
  Three mL peripheral venous blood was taken from 
patients with empty stomach early in the morning. EDTA-
K2 anticoagulant was used to anti-freeze. White blood 
cells were separated by Ficoll solution. DNA was extracted 
by Genomic DNA Extraction Kit (Beijing Bai Taike 
Biotechnology Co., Ltd.).
2.2.2. Detection of K469E polymorphism of ICMA-1 gene
  PCR-RFLP method was  used  to  de tec t  K469E 
polymorphism of ICMA-1 gene. 栙Primer synthesis: 
the primer was synthesized by Beijing SaiBaiSheng Co. 
Ltd. The upstream primer and downstream primer were 
respectively 5’-GGAACCCATTGCCCGAG-C-3’ and 5’-
GGTGAGGATTGCATTAGGTC-3’. 栚PCR reaction system: 
total volume 25 毺L, including 20 pmol upstream primer, 
20 pmol downstream primer, 5.0 毺L template DNA, 2.5 毺
L 10暳PCR buffer solution, 2.0 毺L 2.5 mmo1/L dNTPs, 1.25 
毺L Taq DNA polymerase and finally complemented by 
sterile double distilled water to 25 毺L. 栛The conditions of 
PCR amplification: being pre-denatured for 5 min at 94 曟
, denaturation for 45 s at 94 曟, annealing for 60 s at 61 曟 
and being stretched for 60 s at 72 曟, the above four steps 
were repeated for 35 times; being stretched for 5 min at 
72 曟. 栜Restriction enzyme digestion and electrophoresis: 
10 毺L PCR amplification products were collected, mixed 
with 4 urestriction enzyme BstU I (British Biolabs Company) 
and hatched for 5 h at 60 曟. After all the reactions, enzyme-
digested products were examined by 3% agarose gel 
electrophoresis. Then the products were stained by ethidium 
bromide and the results of genotypes were read by gel 
electrophoresis imaging instrument. 
2.2.3. Follow-up visit
  After patients left the hospital, the smoking, drinking, 
blood fat, blood sugar, history of diabetes mellitus, family 
history of stroke, history of hypertension, recurrence and 
death events were followed up for 5 years through telephone 
and standard questionnaire.
2.3. Statistical methods
  All the data were analyzed statistically with software SPSS 
17.0, comparisons of indexes such as characteristics of 
different genotypes of demography, smoking, drinking, blood 
fat, blood sugar, history of diabetes mellitus, family history 
of stroke, history of hypertension and so on were tested by 
t and氈
2. Gene polymorphism of ICAM-1 and the relation 
between other dangerous factors and the recurrence of ACS 
and cardiovascular mortality were analyzed by gradually 
non-conditional Logistic regression. Relative risk was 
expressed by oddsrations (OR) and 95% confidence intervals 
(CI). The difference had statistical significance as P<0.05.
  
3. Results
3.1. Analysis of ICAM-1 genotype 
  Mutation happened at exon 6 A濚G site of ICAM-1 gene, 
which directly affected the change from 469 amino acid K 
(lysine coded by the gene) to glutamic acid E. The length of 
ICAM-1PCR amplification fragment was 223 bp. According 
to the state of fragments, there were three genotypes: 
genotype KK (only one band 223 bp), genotype KE (three 
bands: 223 bp, 136 bp and 87 bp) and genotype EE (two 
bands: 136 bp and 87 bp). See Figure 1.  
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Figure 1. Electrophoretogram of ICAM-1 K469E genotype.
Note: M: DL 2000 DNA marker; 1, 2: Genotype KK; 3, 4: Genotype EE; 
5, 6: Genotype KE.
3.2. Comparison of clinical features in group with K 
(KK+KE) allele and group without K allele (EE)
  During the five-year follow-up visit, ACS recurred on 
71 cases (38.4%) and 10 cases died, among which 3 cases 
died of cardiovascular disease. The recurrence of ACS, 
cardiovascular mortality, history of diabetes mellitus and 
the level of HDL-C were all remarkably higher than those in 
group without K allele (EE) (P<0.01). There was no statistical 
significance in the difference of constituent ratio of ages and 
genders in the two groups, weight index, TC, LDL-C, TG, 
smoking, drinking, family history of cardiovascular diseases, 
history of hypertension and the scores of the severity of 
coronary artery disease (P>0.05). See Table 1.  
3.3. Analysis of correlation between K469E polymorphism of 
ICAM-1 gene and the risk of ACS recurrence  
  ICAM-1 gene, age, gender, weight index, TC, LDL-C, TG, 
smoking, drinking, family history of cardiovascular diseases, 
history of hypertension and the severity of coronary artery 
disease were considered as independent variables and 
whether ACS recurred or not was considered as a dependent 
variable. The results of Logistic regression analysis showed 
that the risk of ACS recurrence in group with K allele was 
3.31 times of that in group without K allele (OR=3.31, 95%CI 
was within 1.46-8.02, P<0.01). When the independent 
variable of hypertension was introduced in regression 
analysis, the risk of ACS recurrence in group with K allele 
decreased (OR=3.02, 95%CI was within 1.01-9.07, P=0.03). 
When the independent variable of HDL-C was introduced, 
different genotypes of ICAM-1 weren’t relevant with ACS 
recurrence (P=0.24). See Table 2.
Table 1  
Comparison of clinical features of different genotypes of ICAM-1 gene K469E (mean暲sd).
Clinical features Group with genotype EE
 (n=1169) 
Group with genotype KK+KE
 (n=69)
Value of t or 氈
2 P Value
Age/Year 58.60暲9.70 59.10暲10.50 0.33 >0.05
Male/case (%) 79(68.1) 49(71.0) 0.06 >0.05
Weight index 24.30暲3.70 24.60暲4.00 0.52 >0.05
TC (mmol/L)   4.84暲2.35   5.06暲3.15 0.54 >0.05
HDL-C (mmol/L)   0.98暲0.37   1.13暲0.42 2.53 <0.05
LDL-C (mmol/L)   2.99暲0.96   3.05暲0.78 0.44 >0.05
TG (mmol/L)   1.90暲0.60   1.85暲0.72 0.51 >0.05
Smoking/case (%) 60(51.7) 32(46.4) 0.30 >0.05
Drinking/case (%) 41(35.3) 27(39.1) 0.13 >0.05
Family history of cardiovascular disease/case (%) 13(11.2)   5(7.2) 0.39 >0.05
History of hypertension/case (%) 72(62.1) 38(55.1) 0.61 >0.05
History of diabetes mellitus /case (%) 15(12.9) 19(27.5) 5.22 <0.05
Severity of coronary artery disease (Gensini score)/point 61.43暲18.57 62.25暲17.30 0.29 >0.05
ACS recurrence/case (%) 37(31.9) 34(49.3) 4.81 <0.05
Cardiovascular Death/case (%) 16(13.8) 20(29.0) 5.44 <0.05
Table 2 
Correlation between K469E polymorphism of ICAM-1 gene and the recurrence of acs and the risk of cardiovascular death.
Ratio of the risk of ACS recurrence OR (95%CI) Ratio of the risk of cardiovascular death OR (95%CI)
Genotype EE Genotype KK+KE P Value Genotype EE Genotype KK+KE P Value
A 1.0 3.31(1.46-8.02) 0.00 1.0 3.53((1.54-8.47) 0.00
B 1.0 3.02(1.01-9.07) 0.03 1.0 3.16(1.09-9.52) 0.02
C 1.0 1.26(0.86-4.79) 0.24 1.0 1.45(0.69-3.08) 0.32
Note: A: the results based on the independent variables (ICAM-1 gene, age, gender, weight index, TC, LDL-C, TG, smoking, drinking, family 
history of cardiovascular diseases, history of hypertension and the scores of the severity of coronary artery disease); B: results after history of 
hypertension was added in variables; C: results after history of hypertension and HDL-C were added in variables. 
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3.4. Analysis of correlation between K469E polymorphism of 
ICAM-1 gene and the risk of cardiovascular death
  The results of Logistic regression analysis showed that the 
risk of cardiovascular death in group with K allele was 3.53 
times of that in group without K allele (OR=3.53, 95%CI was 
within 1.54-8.47, P<0.01). When the independent variable 
of hypertension was introduced in regression analysis, 
the risk of cardiovascular death in group with K allele 
decreased (OR=3.16, 95%CI was within 1.09-9.52, P=0.02). 
When the independent variable of HDL-C was introduced 
again, different genotypes of ICAM-1 weren’t relevant with 
cardiovascular death (P=0.32). See Table 2.
4. Discussion
  ICAM-1 belongs to the super-family of immunoglobulin, 
composed of 507 amino acids and expressing extensively on 
the surface of endothelial cells, macrophage and activated 
leukomonocyte. It mediates the adhesion of vascular 
endothelial cells and white blood cells through combining 
with function associated antigen of its ligand lymphocyte 
and plays an essential role in the inflammatory mechanism 
of atherogenesis[5-7]. Its coding gene is located in p13.3- 
p13.2 of human chromosome 19 with the total length of 15.5 
kb, including 7 exons and 6 introns. The sixth exon has a 
common polymorphism (A濚G), influencing 469th codon 
(AAG濚GAG) and finally causing lysine to glutamic acid. 
And such gene mutation may affect the Plasma concentration 
and activity of ICAM-1[8,9]. Currently, Many studies in 
domestic and abroad reported that K496E polymorphism 
was related to the occurrence of myocardial infarction and 
stroke[10-12]. However, there was no report about the study of 
K496E polymorphism and the recurrence and risk of death of 
heart or brain vessels disease.     
  After five years’ follow-up visit of 185 ACS patients, it was 
found that ACS recurred on 71 cases (38.4%) and 10 cases 
died, among which 3 cases died of cardiovascular disease. 
The recurrence of ACS and cardiovascular mortality in 
group with K allele (KK+KE) were remarkably higher than 
that in group without K allele (EE) (P<0.01), indicating K 
allele increased the risk of the recurrence and death of 
ACS. It alsofurther analyzed whether interactions between 
K469E polymorphism of ICAM-1 gene and age, gender, 
hypertension, diabetes mellitus and abnormal blood 
lipids or not. When ICAM-1 gene, age, gender, weight 
index, TC, LDL-C, TG, smoking, drinking, family history 
of cardiovascular diseases, history of hypertension and 
the severity of coronary artery disease were considered as 
independent variables and whether ACS recurred or not was 
considered as a dependent variable, the results of Logistic 
regression analysis showed that the risk of ACS recurrence 
in group with K allele was 3.31 times of that in group without 
K allele (OR=3.31, 95%CI was within 1.46-8.02, P<0.01). If 
cardiovascular death was considered as dependent variable, 
the results of Logistic regression analysis showed that the 
risk of cardiovascular death in group with K allele was 3.53 
times of that in group without K allele (OR=3.53, 95%CI was 
within 1.54-8.47, P<0.01), indicating that K allele may be one 
of the independent and dangerous factors of ACS recurrence 
and cardiovascular death[13]. When the independent variable 
of hypertension was introduced in regression analysis, 
the risks of ACS recurrence and cardiovascular mortality 
in group with K allele both decreased (P=0.03, OR=3.02; 
P=0.02, OR=3.16). When the independent variable of HDL-C 
was introduced again, different genotypes of ICAM-1 
weren’t relevant with ACS recurrence and cardiovascular 
mortality (P=0.24, OR=1.26; P=0.32, OR=1.45). The above 
results revealed that K469E polymorphism of ICAM-1 may 
contribute to the recurrence of ACS and cardiovascular 
death by affecting hypertension and HDL-C.
  The study found that the difference had no statistical 
significance in the comparison of the severity of coronary 
artery diseases in two groups (P>0.05), indicating that 
there was no obvious relation between ACS recurrence, 
cardiovascular death and the severity of coronary artery 
diseases. The pathogenesis of ACS was caused by unstable 
atherosclerotic plaque falling apart and consequently led 
to the thrombogenesis. And plaques often fell apart at 
the moderately narrow places in coronary artery, so the 
occurrence of ACS mainly depent on the stability of plaques 
rather than the degree of coronary artery stenosis[14,15]. 
ICAM-1 gene probably affected ACS recurrence and 
cardiovascular death through triggering the unstability of 
plaques rather than aggravating the severity of coronary 
artery[16]. The study also found that there were relatively 
more cases with diabetes mellitus in group with genotype 
KK+KE (27.5% vs. 12.9%, P<0.05). Some studies[17] found that 
diabetes mellitus and secondary insulin resistance were 
dangerous factors of ACS recurrence, but whether the higher 
risk of ACS recurrence in group with K allele is related to 
the history of diabetes mellitus needs further study.
  In conclusion, ICAM-1 K469E polymorphism may be one 
of the dangerous genetic factors of ACS recurrence and 
cardiovascular death and the pathogenesis was related to 
hypertension, HDL-C and stability of plaque. But ACS was a 
disease of multi-factorial inheritance and closely related to 
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environmental factors. The interactions of gene to gene and 
gene to environment need further reaearch[18,19]. Besides, 
ethnic difference of study objects, sample capacity and 
detail methods as well as diagnostic standards are main 
factors of the occurrence of heterogenicity[20]. Therefore, 
such a conclusion needs more comprehensive samples to 
verify. If the results can be ensured, it would be remarkably 
helpful for the individual prevention and treatment. 
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